Before the announcement, the European agency had been processing 19 applications for CBD products, all of which are now in limbo.
Can psychedelic drugs help scientists to solve their technical problems? Yes, according to one recent review.
Regulators in Vermont have reportedly licensed the state’s first recreational cannabis testing lab.
In this exclusive Analytical Cannabis article, Dr. Karen Litwa and Dr. Ken Soderstrom of East Carolina University’s Brody School of Medicine explain why cannabis can both help people living with autism and also contribute to the development of the condition during pregnancy.
Kimberly Ross, the chief scientific officer at Peak Compliance, explores the future of cannabis testing in the US, should federal legalization take effect.
A new review of 25 studies trials has concluded that oral synthetic cannabis products with high amounts of THC can result in moderate short-term improvements in chronic pain.
Cannabis Use Disorder is the most common illicit drug use disorder in the United States and is hallmarked by cravings and other physical withdrawal symptoms when cannabis is not used.
While effective treatments for opioid addictions have been available, this could be the first dedicated treatment for cocaine addiction, which is a global crisis.
From next year, Canadians living in the province of British Columbia will be able to possess opioids, cocaine, methamphetamine, and MDMA, the country’s government has announced.